New Horizons
Exploring future technologies, using rationality to understand our world, and occasional forays into philosophy and other topics of interest.
- Indexed episodes, last 90 days
- 3
- Latest publication
- Sep 7, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 22, 2026
Latest episodes
S2E3: Niklas Anzinger - The Promise of Charter Cities (opens the original)
Read excerpt
It now takes around fourteen years and hundreds of millions of dollars to get a new drug approved in the United States — up from about four years in 1962. And despite decoding the human genome, AI for protein folding, and computational biology, the cost of developing an approved drug roughly doubles every nine years. Some call this Eroom's Law: Moore's Law in reverse.We sit down with Niklas Anzinger, founder and CEO of Infinita, which is building a biotech district in Próspera — the special econ
S2E2: David Pearce - Engineering a World Without Suffering: Is it Possible? (opens the original)
Read excerpt
What if suffering isn't an unavoidable feature of conscious life, but a solvable engineering problem? Philosopher David Pearce has spent three decades arguing that we could — and morally should — use biotechnology to abolish suffering entirely, not just in humans but across all sentient life.We sit down with David Pearce, co-founder of the World Transhumanist Association (now Humanity+) alongside Nick Bostrom, and author of the 1995 manifesto The Hedonistic Imperative. His recent work with the F
S2E1: Aurelia Song - Cryonics, Mind Uploading, and the Science of Preservation (opens the original)
Read excerpt
Cryonics has been around since the 1960s, but it's never had a good answer to a basic question: does it actually work? For most of its history, nobody could show that the preservation techniques being sold to dying people were saving anything at all. In the first episode of Season 2, we sit down with Aurelia Song, founder and CTO of Nectome, who spent a decade trying to fix that. Her technique — aldehyde-stabilized cryopreservation — won both the small and large mammal prizes from the Brain Pres
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.